LivaNova PLC
$65.81
▼
-1.3%
2026-04-21 07:54:01
www.livanova.com
NMS: LIVN
Explore LivaNova PLC stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.6 B
Current Price
$65.81
52W High / Low
$71.92 / $34
Stock P/E
—
Book Value
$21.96
Dividend Yield
—
ROCE
11.09%
ROE
-19.24%
Face Value
—
EPS
$-4.45
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
3,300
Beta
0.97
Debt / Equity
36.15
Current Ratio
1.36
Quick Ratio
1.16
Forward P/E
13.71
Price / Sales
2.47
Enterprise Value
$3.23 B
EV / EBITDA
12.54
EV / Revenue
2.33
Rating
Buy
Target Price
$79.64
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Insulet Corporation | $193.4 | 55.6 | $13.48 B | — | 18.87% | 18.12% | $354.88 / $194.61 | $21.53 |
| 2. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 3. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 4. | STERIS plc | $223.73 | 31.17 | $21.95 B | 1.11% | 10.53% | 10.47% | $269.44 / $209.98 | $72.93 |
| 5. | Sintx Technologies, Inc. | $2.78 | — | $11.46 M | — | -185.71% | -3.04% | $6.78 / $1.72 | $0.74 |
| 6. | Profusa, Inc. | $0.66 | — | $3.05 M | — | 8.32% | 8.05% | $957 / $0.41 | $-61.03 |
| 7. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 360.92 M | 357.75 M | 352.52 M | 316.86 M | 321.83 M | — |
| Operating Profit | 42.58 M | 54.01 M | 54.18 M | 48.62 M | 37.02 M | — |
| Net Profit | 30.91 M | 26.78 M | 27.16 M | -327.32 M | 55.89 M | — |
| EPS in Rs | 0.57 | 0.49 | 0.5 | -5.99 | 1.02 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.39 B | 1.25 B | 1.15 B | 1.02 B |
| Operating Profit | 199.39 M | 129.05 M | 21.48 M | 52.64 M |
| Net Profit | -242.47 M | 63.23 M | 17.55 M | -86.25 M |
| EPS in Rs | -4.43 | 1.16 | 0.32 | -1.58 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.61 B | 2.51 B | 2.43 B | 2.29 B |
| Total Liabilities | 1.41 B | 1.19 B | 1.15 B | 1.09 B |
| Equity | 1.2 B | 1.32 B | 1.28 B | 1.21 B |
| Current Assets | 1.1 B | 1.13 B | 988.16 M | 886.14 M |
| Current Liabilities | 808.07 M | 392.12 M | 334.98 M | 297.4 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 254.34 M | 183.04 M | 74.91 M | 69.92 M |
| Investing CF | -72.91 M | -48.16 M | -40.33 M | -38.41 M |
| Financing CF | -285.66 M | 18.55 M | 21.48 M | 280.13 M |
| Free CF | 173.29 M | 135.93 M | 39.93 M | 43.4 M |
| Capex | -81.05 M | -47.11 M | -34.98 M | -26.52 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 8.66% | 12.89% | — | — |
| Earnings Growth % | 260.39% | 120.34% | — | — |
| Profit Margin % | 5.04% | 1.52% | -8.44% | — |
| Operating Margin % | 10.3% | 1.86% | 5.15% | — |
| Gross Margin % | 68.09% | 65.52% | 69.21% | — |
| EBITDA Margin % | 16.16% | 3.34% | 3.02% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.